お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974425

PCRの世界市場:将来予測 (qPCR、dPCR、シングルプレックス、マルチプレックス)、企業経営陣・コンサルタント向けガイド、カスタム型の市場予測・分析 (2021年~2025年) - 新型コロナウイルス感染症 (COVID-19) 向け診断需要の影響を含む

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of COVID-19 Diagnostics 2021 to 2025

出版日: | 発行: Howe Sound Research | ページ情報: 英文 363 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
PCRの世界市場:将来予測 (qPCR、dPCR、シングルプレックス、マルチプレックス)、企業経営陣・コンサルタント向けガイド、カスタム型の市場予測・分析 (2021年~2025年) - 新型コロナウイルス感染症 (COVID-19) 向け診断需要の影響を含む
出版日: 2020年12月08日
発行: Howe Sound Research
ページ情報: 英文 363 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のPCR (ポリメラーゼ連鎖反応) 市場の最新動向と将来展望について分析し、技術の概略や主な活用分野、主な市場促進・抑制要因、昨今の技術開発・市場拡大の動き、主要企業のプロファイル、全体的な市場規模の動向見通し、国別・用途別・技術別の詳細動向、業界関係者向け提言、といった情報を取りまとめてお届けいたします。

目次

マーケットガイド

  • 状況分析
  • 企業経営陣・マーケティングスタッフのためのガイド
  • 投資アナリスト・経営コンサルタントのためのガイド

第1章 イントロダクション・市場定義

  • PCR技術とは何か
  • PCR検査と各種症候群の検査
  • 市場の定義
  • 分析手法
  • 米国の医療市場と臨床検査:展望
    • 米国の臨床検査向けメディケア支出

第2章 PCR (ポリメラーゼ連鎖反応):PCR技術のガイド

  • 概念
    • 方法
  • 活用分野
    • 特定のDNAの判定
    • DNAの測定
    • 医療・診断用途
  • PCR:長所と短所
  • 各種のPCR
    • 簡単な変更
    • デジタルPCR
    • 等温PCR

第3章 業界の概要

  • ダイナミックな市場の参入企業
    • 教育機関の研究室
    • 診断検査の開発企業
    • ゲノム計装サプライヤー
    • 医薬品/試薬サプライヤー
    • 独立型検査室
    • 公立 (国立/地域) 検査室
    • 病院検査室
    • 医師ラボ
    • 監査機関
    • 認証機関

第4章 市場動向

  • 市場促進要因
    • 新しい基準
    • 価格曲線に沿った価格の低下
    • 多重化
    • 症候群の診断:市場の更なる成長の見通し
    • 「遺伝子の猛吹雪」
  • 市場抑制要因
    • コスト曲線
    • 他の要因
    • 全身性障害
  • 診断技術の発展
    • 計測曲線
    • 診断部門の役割の変化
    • 診断部門の病院からの独立
    • 混乱の出現
    • 次の5年間の動向見通し

第5章 PCR市場の最新動向

第6章 主要なPCR企業のプロファイル

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

第7章 PCR市場

  • 世界のPCR市場の概要:国別

第8章 世界のPCR市場:用途別

  • 世界市場の概況:用途別
  • PCRマルチプレックス
  • PCRシングルプレックス
  • PCR研究
  • PCRシングルC19
  • その他のPCR

第9章 世界のPCR市場:技術別

  • 世界市場の概要:技術別
  • qPCR
  • dPCR
  • シングルC19PCR

付録

  • 米国のメディケア精度:臨床検査料金スケジュール (2020年)
図表

Table of Tables

  • Table 2: Lab Spending 2014 to 2024
  • Table 3: Market Players by Type
  • Table 4: Five Factors Driving Growth
  • Table 5: Three Factors Limiting Growth
  • Table 6: Global PCR Market by Region
  • Table 7: Global Market by Application
  • Table 8: PCR Clinical Multiplex by Country
  • Table 9: PCR Clinical Singleplex by Country
  • Table 10: PCR Research by Country
  • Table 11: PCR Single C19 by Country
  • Table 12: PCR Other by Country
  • Table 13: Global Market by Technology
  • Table 14: qPCR by Country
  • Table 15: dPCR by Country
  • Table 16: Single C19 PCR by Country
  • Table 17: 2020 Clinical Lab Fee Schedule
  • Figure 2: Clinical Lab Spending 2014 to 2024
  • Figure 3: The PCR Process
  • Figure 4: Creation of Sample Droplets for Digital PCR
  • Figure 5: Comparing Syndromic and Targeted Testing
  • Figure 6: Comparing The New Diagnostics and Traditional Testing
  • Figure 7: Growth rates of PCR Diagnostic Segments
  • Figure 8: Base year Global Market Share Chart
  • Figure 9: PCR Market by Application - Base vs. final
  • Figure 10: PCR Market Base year
  • Figure 11: PCR Market Final Year
  • Figure 12: Application Share by Year
  • Figure 13: PCR Clinical Multiplex Testing Growth
  • Figure 14: PCR Clinical Singleplex Testing Growth
  • Figure 15: PCR Research Growth
  • Figure 16: PCR Single C19 Growth
  • Figure 17: PCR Other Growth
  • Figure 18: PCR Market by Technology - Base vs. Final
  • Figure 19: PCR Market Base Year
  • Figure 20: PCR Market Final Year
  • Figure 21: Technology Share by Year
  • Figure 22: qPCR Growth
  • Figure 23: dPCR Growth
  • Figure 24: Single C19 PCR Growth
目次

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1. What are PCR Technologies?
  • 1.2. PCR and Syndromic Testing
  • 1.3. Market Definition
    • 1.3.1. Market Size
    • 1.3.2. Currency
    • 1.3.3. Years
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. PCR-Guide to PCR Technologies

  • 2.1. Concepts
    • 2.1.1. Method
  • 2.2. Applications
    • 2.2.1. Finding Specific DNA
    • 2.2.2. Measuring DNA
    • 2.2.3. Medical and diagnostic applications
      • 2.2.3.1. Carrier, prenatal and tissue typing
      • 2.2.3.2. Cancer Diagnosis and Management
      • 2.2.3.3. Infectious disease-New Levels of Accuracy and Sensitivity
      • 2.2.3.4. Forensic applications
      • 2.2.3.5. Science and Research
  • 2.3. PCR-Advantages and Disadvantages
  • 2.4. Different Types of PCR
    • 2.4.1. Simple Changes
      • 2.4.1.1. Multiplex-PCR
      • 2.4.1.2. VNTR PCR
      • 2.4.1.3. Asymmetric PCR
      • 2.4.1.4. Long PCR
      • 2.4.1.5. Nested PCR
      • 2.4.1.6. Quantitative PCR
      • 2.4.1.7. Hot-start PCR
      • 2.4.1.8. Touchdown PCR
      • 2.4.1.9. Assembly PCR
      • 2.4.1.10. Colony PCR
      • 2.4.1.11. Suicide PCR
      • 2.4.1.12. Cold PCR
    • 2.4.2. Digital PCR
      • 2.4.2.1. Droplet Digital PCR
      • 2.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 2.4.2.3. Digital PCR in Use
      • 2.4.2.4. Digital PCR Commercial History
    • 2.4.3. Isothermal PCR

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Genomic Instrumentation Supplier
      • 3.1.3.1. Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4. Pharmaceutical/Reagent Supplier
    • 3.1.5. Independent Testing Lab
    • 3.1.6. Public National/regional lab
    • 3.1.7. Hospital lab
    • 3.1.8. Physician Lab
    • 3.1.9. Audit Body
    • 3.1.10. Certification Body

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Standard
    • 4.1.2. Down the Curve We Go
    • 4.1.3. Multiplexing
    • 4.1.4. Syndromic Diagnostics Looks Unstoppable
    • 4.1.5. The Genetic Blizzard
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Cost Curve
    • 4.2.2. The Other Guys
    • 4.2.3. Systemic Roadblocks
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Instrumentation Curve
    • 4.3.2. Shifting Role of Diagnostics
    • 4.3.3. Diagnostics Moves Out of the Hospital
    • 4.3.4. Disruption Looms
    • 4.3.5. The Next Five Years

5. PCR Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
      • Scope Fluidics Secures €6.2M Supporting Rapid MDx
      • Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
      • Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
      • Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
      • Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
      • HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
      • Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
      • Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
      • DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
      • Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
      • ChromaCode Raises $28M based on new High Definition PCR Technology
      • ddPCR Used for Fast and Low-Cost NIPT Screening
      • Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
      • Bio-Rad's ddPCR MSI RUO Assay is available
      • ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
      • Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
      • QIAGEN Plans for Next-Generation Digital PCR Systems
      • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
      • New PCR Technology: Transfer-PCR (tPCR) Applications
      • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
      • Natera Applies Massively Multiplexed PCR to Kidney Transplants
      • Paragon Genomics, MGI Tech Form Distribution Alliance
      • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
      • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
      • Bruker to Acquire Majority in Hain Lifescience GmbH
      • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
      • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
      • PredictImmune Wins £100K Grant for Study of IBD Prognostic
      • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
      • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
      • Bio-Rad Wins USDA Food Safety Testing Contract
      • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets

  • 7.1. PCR-Global Market Overview by Country
    • 7.1.1. Table-Global Market by Country
    • 7.1.2. Chart - Global Market by Country

8. Global PCR Markets-By Application

  • 8.1. Global Market by Application - Overview
    • 8.1.1. Table-Global Market by Application
    • 8.1.2. Chart-Global Market by Application-Base/Final Comparison
    • 8.1.3. Chart-Global Market by Application-Base Year
    • 8.1.4. Chart-Global Market by Application-Final Year
    • 8.1.4. Chart-Global Market by Application-Share by Year
  • 8.2. PCR Clinical Multiplex
    • 8.2.1. Table PCR Clinical Multiplex Testing-by Country
    • 8.2.2. Chart - PCR Clinical Multiplex Testing Growth
  • 8.3. PCR Clinical Singleplex
    • 8.3.1. Table PCR Clinical Singleplex Testing-by Country
    • 8.3.2. Chart - PCR Clinical Singleplex Testing Growth
  • 8.4. PCR Research
    • 8.4.1. Table PCR Research-by Country
    • 8.4.2. Chart - PCR Research Growth
  • 8.5. PCR Single C19
    • 8.5.1. Table PCR Single C19-by Country
    • 8.5.2. Chart - PCR Single C19 Growth
  • 8.6. PCR Other
    • 8.6.1. Table PCR Other-by Country
    • 8.6.2. Chart - PCR Other Growth

9. Global PCR Markets-By Technology

  • 9.1. Global Market by Technology - Overview
    • 9.1.1. Table-Global Market by Technology
    • 9.1.2. Chart-Global Market by Technology-Base/Final Comparison
    • 9.1.3. Chart-Global Market by Technology-Base Year
    • 9.1.4. Chart-Global Market by Technology-Final Year
    • 9.1.4. Chart-Global Market by Technology-Share by Year
  • 9.2. qPCR
    • 9.2.1. Table qPCR-by Country
    • 9.2.2. Chart - qPCR Growth
  • 9.3. dPCR
    • 9.3.1. Table dPCR-by Country
    • 9.3.2. Chart - dPCR Growth
  • 9.4. Single C19 PCR
    • 9.4.1. Table Single C19 PCR-by Country
    • 9.4.2. Chart - Single C19 PCR Growth

Appendices

  • I. United States Medicare System: 2020 Clinical Laboratory Fees Schedule
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.